Cancer Vaccines
Interleukin-2 Enhances Therapeutic Anticancer Vaccines
Published in Vaccine Weekly, April 5th, 2000
"The purpose of our efforts is to trigger the immune destruction of established cancer," W.W. Overwijk and colleagues, U.S. National Cancer Institute, Maryland. "Interleukin (IL)-2 can mediate the regression of tumors in patients with melanoma and renal cell carcinoma."
Overwijk et al. published the results of their study in the Cancer Journal from Scientific American ("The future of interleukin-2: Enhancing therapeutic anticancer vaccines," Cancer J Sci Am, 2000;6(Suppl. 1):S76-S80).
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2000-04-05)
More Articles from Vaccine Weekly
- Malaria
MAP Vaccine Tested for Safety and Immunogenicity in Phase I Trial - Cancer Vaccines
Genetic Vaccination with Self Protein Eradicates Melanoma in a Murine Model - Cancer Vaccines
IL-2 Potentiates Immunologic Response of Dendritic-Cell-Based Tumor Vaccines - Immunization
Childhood Vaccination Rates Affected by Several Factors - Influenza Vaccines
Intranasal Vaccine Safe, Efficacious - Pneumococcal Immunization
Vaccine Safe in Renal Transplant Recipients - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
